Follow
Suraj Hettiarachchi
Suraj Hettiarachchi
Investigator, GSK
Verified email at gsk.com
Title
Cited by
Cited by
Year
Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore
SU Hettiarachchi, B Prasai, RL McCarley
Journal of the American Chemical Society 136 (21), 7575-7578, 2014
1742014
Cascade reaction-based, near-infrared multiphoton fluorescent probe for the selective detection of cysteine
RR Nawimanage, B Prasai, SU Hettiarachchi, RL McCarley
Analytical chemistry 89 (12), 6886-6892, 2017
1032017
Human NAD (P) H: quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups
MF Mendoza, NM Hollabaugh, SU Hettiarachchi, RL McCarley
Biochemistry 51 (40), 8014-8026, 2012
682012
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
SU Hettiarachchi, YH Li, J Roy, F Zhang, E Puchulu-Campanella, ...
Science translational medicine 12 (567), eaay3724, 2020
622020
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
F Zhang, B Wang, E Puchulu-Campanella, YH Li, SU Hettiarachchi, ...
D109. MODULATING THE FIBROTIC RESPONSE, A7872-A7872, 2020
612020
Rapid, photoinduced electron transfer-modulated, turn-on fluorescent probe for detection and cellular imaging of biologically significant thiols
RR Nawimanage, B Prasai, SU Hettiarachchi, RL McCarley
Analytical chemistry 86 (24), 12266-12271, 2014
482014
Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents
J Roy, SU Hettiarachchi, M Kaake, R Mukkamala, PS Low
Theranostics 10 (13), 5778-5789, 2020
312020
Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
PS Low, SU Hettiarachchi, LI Yen-Hsing, ROY Jyoti
US Patent 11,426,472, 2022
22022
Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
PS Low, SU Hettiarachchi, LI Yen-Hsing, ROY Jyoti
US Patent 11,890,357, 2024
2024
FIBROBLAST ACTIVATION PROTEIN (FAP) TARGETED IMAGING AND THERAPY IN FIBROSIS
J LOW, Philip S. HETTIARACHCHI, Suraj U. LI, Yen-Hsing ROY
US Patent PCT/US2019/056,257, 2020
2020
Targeting myofibrobasts for novel imaging and therapeutic applications in idiopathic pulmonary fibrosis
H SU, et. al
Am. J. Respir. Crit. Care. Med, 199:A4087, 2019
2019
Near-infrared, wavelength-shiftable, turn-on fluorescent probe for the detection and imaging of an intracellular enzyme upregulated in cancer cells
Z Shen, B Prasai, S Hettiarachchi, R McCarley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Design, Synthesis, and Evaluation of Small Molecule-based, Profluorogenic Activatable Substrate Probes for Detection and Visualization of Human Cancer Enzyme NAD (P) H: Quinone …
SU Hettiarachchi
Louisiana State University and Agricultural & Mechanical College, 2015
2015
Highly selective cloaked fluorogenic probes for detection and imaging of disease markers
RL McCarley, SU Hettiarachchi, Q Best, WC Silvers, B Prasai, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014
2014
Cancer cell detection and imaging via enzyme-activation of cloaked fluorophore probes
RL McCarley, SU Hettiarachchi, B Prasai, R Nawimanage, Q Best
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014
2014
Profluorogenic NIR turn-on-substrate-probe for cellular imaging
SU Hettiarachchi, B Prasai, RL McCarley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014
2014
Cloaked fluorophores with novel self-immolative redox-gated triggers
SU Hettiarachchi, RL McCarley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
Redox-gated self-immolative liposomal drug delivery systems
SU Hettiarachchi, RL McCarley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 243, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–18